Work

A phase III randomized trial of cisplatin and paclitaxel administered by either 24 hour or 96 hour infusion in patients with selected stage III or stage IV epithelial ovarian cancer (GOG162)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.5004

Authors: D. R. Spriggs, M. Brady, S. Rubin, M. Hanley, L. J. Copeland, D. Clarke-Pearson, R. Burger

Institutions: Gynecologic Oncology Group, Memorial Sloan Kettering Cancer Center, Duke University, University of California, Irvine, The Ohio State University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602326500

Cites:

Cited by: 8

Related to: 10